A double-blind trial of phenelzine in bulimia.
Thirty normal weight women with bulimia completed a double-blind, placebo-controlled trial of phenelzine sulfate. The results demonstrate a significant therapeutic advantage for phenelzine over placebo. Preliminary data suggest that phenelzine may be of benefit even to non-depressed patients with bulimia.
D000293:Adolescent; D000328:Adult; D002986:Clinical Trials as Topic; D003866:Depressive Disorder / Q000188:drug therapy; D004311:Double-Blind Method; D001068:Feeding and Eating Disorders / Q000188:drug therapy*; D005260:Female; D006801:Humans; D006963:Hyperphagia / Q000188:drug therapy* / Q000523:psychology; D008875:Middle Aged; D010624:Phenelzine / Q000627:therapeutic use*; D011581:Psychological Tests
D010624:Phenelzine